text
"['\n4. 매출 및 수주상황\n가. 매출실적\n\xa0 \xa0 \xa0 ( 단위 : 백만원 )\n구분\n사업부문\n품목\n구분\n제52 기\n제51 기\n제50 기\n계속영업사업\n산업설비공사\n산업설비플랜트E.P.C\n수출\n84\n1,181\n1,723\n내수\n120,255\n70,505\n70,098\n합계\n120,339\n71,686\n71,821\n화장품\n노보스트라타 등\n수출\n-\n-\n-\n내수\n351\n402\n649\n합계\n351\n402\n649\n건강식품\n스위치온 등\n수출\n-\n-\n-\n내수\n2,371\n1,253\n-\n합계\n2,371\n1,253\n-\n셀론텍\n리젠씰, 카티졸 등\n수출\n-\n-\n-\n내수\n14,150\n2,345\n-\n합계\n14,150\n2,345\n-\n기타\n젠바디 등\n수출\n-\n-\n-\n내수\n13\n39\n-\n합계\n13\n39\n-\n소계\n수출\n84\n1,181\n1,723\n내수\n137,140\n74,544\n70,747\n합계\n137,224\n75,725\n72,470\n중단영업사업\n세원이앤씨_PE\n열교환기,반응기 등\n수출\n-\n-\n42,401\n내수\n-\n-\n8,722\n합계\n-\n-\n51,123\n세원이앤씨_PL\nVALVE 등\n수출\n-\n-\n10\n내수\n-\n-\n2,713\n합계\n-\n-\n2,723\n세원이앤씨_RMS\n세포치료제,가족제대혈은행\n수출\n-\n-\n163\n내수\n-\n-\n12,216\n합계\n-\n-\n12,379\n상해세원액압유한공사\nVALVE 등\n수출\n-\n-\n-\n내수\n-\n-\n179\n합계\n-\n-\n179\n셀론텍\n콘드론, 오스론,베이비셀\n수출\n-\n-\n내수\n-\n147\n합계\n-\n147\n소계\n수출\n84\n-\n42,574\n내수\n137,140\n147\n23,830\n합계\n137,224\n147\n66,404\n나. 수주상황\n\xa0 \xa0 \xa0 ( 단위 : 천원 )\n구분\n기초\n증감액\n공사수익인식\n기말\n산업설비공사\n103,360,562\n128,274,143\n(124,755,043)\n106,879,662\n다. 진행률 적용 수주 현황\n(단위: 천원)\n계약처\n계약일자\n계약상완성기한\n진행률\n수주총액\n계약자산\n매출채권\n총액\n손상차손누계액\n총액\n대손충당금\n셀론텍㈜\n19/12/04\n23/10/31\n64%\n31,000,000\n1,783,600\n-\n-\n-\n스미세이케미칼㈜\n21/04/01\n22/11/30\n100%\n16,630,050\n-\n-\n-\n-\n한화솔루션\n21/04/06\n22/12/30\n100%\n34,248,599\n1,496,000\n-\n694,738\n-\n금호미쓰이화학㈜\n21/06/29\n23/04/30\n85%\n30,398,600\n935,496\n-\n1,219,020\n-\n티이엠씨 주식회사\n21/11/16\n22/11/30\n100%\n7,066,900\n108,000\n-\n-\n-\n금호석유화학(주)여수정밀화학\n21/12/17\n23/06/30\n54%\n22,440,000\n-\n-\n2,356,200\n-\n에스케이 트리켐 주식회사\n22/03/21\n23/02/15\n90%\n29,967,000\n921,005\n-\n1,317,712\n-\n에어리퀴드어드밴스드머티리얼즈\n22/06/07\n23/11/20\n14%\n62,600,000\n-\n-\n6,712,830\n-\n에스케이 트리켐 주식회사\n22/10/19\n23/06/30\n13%\n4,188,000\n-\n-\n-\n-\n금호미쓰이화학㈜\n22/12/21\n23/12/31\n0%\n5,700,000\n-\n-\n627,000\n-\n금호석유화학(주)여수정밀화학\n22/12/16\n23/07/31\n0%\n7,395,000\n-\n-\n813,450\n-\n']"
